ANIX
Price
$2.92
Change
-$0.05 (-1.68%)
Updated
Jan 23 closing price
Capitalization
94.01M
49 days until earnings call
PRTA
Price
$15.48
Change
+$1.05 (+7.28%)
Updated
Jan 23 closing price
Capitalization
832.96M
20 days until earnings call
Ad is loading...

ANIX vs PRTA

Header iconANIX vs PRTA Comparison
Open Charts ANIX vs PRTABanner chart's image
Anixa Biosciences
Price$2.92
Change-$0.05 (-1.68%)
Volume$89.53K
Capitalization94.01M
Prothena
Price$15.48
Change+$1.05 (+7.28%)
Volume$361.78K
Capitalization832.96M
ANIX vs PRTA Comparison Chart
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. PRTA commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and PRTA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 24, 2025
Stock price -- (ANIX: $2.92 vs. PRTA: $15.48)
Brand notoriety: ANIX and PRTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 73% vs. PRTA: 61%
Market capitalization -- ANIX: $94.01M vs. PRTA: $832.96M
ANIX [@Biotechnology] is valued at $94.01M. PRTA’s [@Biotechnology] market capitalization is $832.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $360.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whilePRTA’s FA Score has 0 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • PRTA’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANIX and PRTA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 3 TA indicator(s) are bullish while PRTA’s TA Score has 2 bullish TA indicator(s).

  • ANIX’s TA Score: 3 bullish, 2 bearish.
  • PRTA’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ANIX is a better buy in the short-term than PRTA.

Price Growth

ANIX (@Biotechnology) experienced а +13.18% price change this week, while PRTA (@Biotechnology) price change was +17.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.04%. For the same industry, the average monthly price growth was +3.42%, and the average quarterly price growth was -1.05%.

Reported Earning Dates

ANIX is expected to report earnings on Mar 14, 2025.

PRTA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+4.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTA($833M) has a higher market cap than ANIX($94M). ANIX YTD gains are higher at: 25.862 vs. PRTA (11.769). ANIX has higher annual earnings (EBITDA): -12.92M vs. PRTA (-167.23M). PRTA has more cash in the bank: 519M vs. ANIX (23.2M). ANIX has less debt than PRTA: ANIX (149K) vs PRTA (11.5M). PRTA has higher revenues than ANIX: PRTA (133M) vs ANIX (0).
ANIXPRTAANIX / PRTA
Capitalization94M833M11%
EBITDA-12.92M-167.23M8%
Gain YTD25.86211.769220%
P/E RatioN/AN/A-
Revenue0133M-
Total Cash23.2M519M4%
Total Debt149K11.5M1%
FUNDAMENTALS RATINGS
ANIX vs PRTA: Fundamental Ratings
ANIX
PRTA
OUTLOOK RATING
1..100
1313
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
9794
PRICE GROWTH RATING
1..100
5587
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRTA's Valuation (62) in the Biotechnology industry is in the same range as ANIX (74) in the Computer Peripherals industry. This means that PRTA’s stock grew similarly to ANIX’s over the last 12 months.

ANIX's Profit vs Risk Rating (98) in the Computer Peripherals industry is in the same range as PRTA (100) in the Biotechnology industry. This means that ANIX’s stock grew similarly to PRTA’s over the last 12 months.

PRTA's SMR Rating (94) in the Biotechnology industry is in the same range as ANIX (97) in the Computer Peripherals industry. This means that PRTA’s stock grew similarly to ANIX’s over the last 12 months.

ANIX's Price Growth Rating (55) in the Computer Peripherals industry is in the same range as PRTA (87) in the Biotechnology industry. This means that ANIX’s stock grew similarly to PRTA’s over the last 12 months.

PRTA's P/E Growth Rating (95) in the Biotechnology industry is in the same range as ANIX (100) in the Computer Peripherals industry. This means that PRTA’s stock grew similarly to ANIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIXPRTA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 17 days ago
83%
Bullish Trend 17 days ago
68%
Momentum
ODDS (%)
N/A
Bearish Trend 17 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 17 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 17 days ago
85%
Bullish Trend 17 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 17 days ago
83%
Bullish Trend 17 days ago
83%
Advances
ODDS (%)
Bullish Trend 22 days ago
83%
Bullish Trend 17 days ago
76%
Declines
ODDS (%)
Bearish Trend 17 days ago
85%
Bearish Trend 23 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 17 days ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 17 days ago
86%
N/A
View a ticker or compare two or three
Ad is loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGISX56.850.31
+0.55%
Hartford Core Equity R4
PEQUX14.820.07
+0.47%
Putnam Focused International Equity A
OPGSX28.090.02
+0.07%
Invesco Gold & Special Minerals A
SLAFX25.67-0.02
-0.08%
DWS Latin America Equity S
STRLX60.32-0.11
-0.18%
Sterling Capital MdCp Relatv Val A

ANIX and

Correlation & Price change

A.I.dvisor tells us that ANIX and GERN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANIX and GERN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-1.85%
GERN - ANIX
33%
Poorly correlated
+1.00%
RYTM - ANIX
28%
Poorly correlated
+2.17%
PRTA - ANIX
27%
Poorly correlated
+7.28%
CDTX - ANIX
27%
Poorly correlated
-0.86%
DNLI - ANIX
27%
Poorly correlated
-0.13%
More

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with PEPG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then PEPG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
+7.28%
PEPG - PRTA
53%
Loosely correlated
-1.52%
DNLI - PRTA
51%
Loosely correlated
-0.13%
BEAM - PRTA
46%
Loosely correlated
-0.38%
NAUT - PRTA
43%
Loosely correlated
-0.50%
XNCR - PRTA
42%
Loosely correlated
-1.02%
More